Sensei Biotherapeutics, Inc. - Common Stock (SNSE)

0.4700Last Price

0.00 (0.00%)Change

Sensei Biotherapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases

The company leverages its proprietary platform to create personalized medicine approaches that harness the power of the immune system to target and combat tumors. By utilizing advanced science and technology, Sensei aims to transform the treatment landscape for patients through the development of novel immune-oncology solutions, with a commitment to improving clinical outcomes and enhancing patient quality of life.

Newman Ferrara LLP Announces Corporate Governance Investigations of Sensei Biotherapeutics, Inc. (SNSE)

Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Sensei Biotherapeutics, Inc. (NASDAQSNSE) (“Sensei” or the “Company”). The investigations concern whether certain of the Sensei’s officers and directors breached their fiduciary duties to shareholders, by, among other things: (i) engaging in self-dealing; (ii) affirmatively approving transactions that harmed the Company; and (iii) failing to provide sufficient oversight of the Company’s business practices.

By Newman Ferrara LLP · Via Business Wire · December 12, 2022

Significant Investor in Sensei Biotherapeutics, Inc. Urges Board to Seek Shareholder Mandate

SLIEMA, Malta, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Apeiron Investment Group Ltd. (together with its affiliates “AIG”), one of the largest shareholders of Sensei Biotherapeutics, Inc. (“Sensei” or the “Company”) (NASDAQSNSE), which beneficially owns approximately 11.2% of the outstanding shares of Sensei’s stock, today announced that it has sent the following letter to Sensei’s Board of Directors (the “Board”).

By Apeiron Investment Group Ltd. · Via GlobeNewswire · November 21, 2022